FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- November 2010
- DOI:
- 10.1371/journal.pone.0013821
- Bibcode:
- 2010PLoSO...513821K